ReviewJournal of thrombosis and thrombolysis2023
Low dose rivaroxaban for the management of atherosclerotic cardiovascular disease.
Placido Maria Mazzone et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it